Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III non-inferiority trial of JTM201 versus Botox for moderate to severe glabellar lines in Chinese subjects
CTR20243520Phase 3Active
- Sponsor
- JETEMA Co., Ltd.
- Start
- Nov 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of botulinum toxin type A in glabellar furrowing, sponsored by JETEMA Co., Ltd.. Started Nov 2024; status: active.
02
Drugs
botulinum toxin type A
03
Conditions
glabellar furrowing
Beyond the preview
Go deeper on CTR20243520.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20243520.